|
|
Elekta AB - Comparative Business Analysis Snapshot
Business Description
Elekta AB. The Group's principal activities are supplying systems and offering clinical solutions for effective treatment of severe diseases including cancer, vascular disorders in the brain, and diseases of the central nervous system such as Parkinson's disease and epilepsy. The Group's products include Leksell Gamma Knife, Neuromag Vectorview, Brain Atlas, Leksell Stereotactic System and PreciseSIM. The principal markets for the Group's products are Europe, North America, Japan and the rest of Asia.
Competitor Analysis
This analysis compares Elekta AB with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
